Drug Pipeline

Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT03813407 An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With… Hyperkalaemia Recruiting
Phase 2
NCT06449222 Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast… Locally Advanced Breast Cancer Active, Not Recruiting
NCT06449209 Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With… Extensive-stage Small-cell Lung Cancer Active, Not Recruiting
Sponsors Running Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1) Trials
BioNTech SE (2) AstraZeneca (1)
Disease Areas
Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free